ArticleAmerican journal of translational research2025
Predictive model for low-molecular-weight heparin ineffectiveness in pregnant and postpartum women with intracranial venous sinus thrombosis: a multicenter study.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop a risk prediction model for low-molecular-weight heparin (LMWH) ineffectiveness in pregnant women with intracranial venous sinus thrombosis (CVST), enabling early identification of high-risk patients.
methodsA retrospective analysis was conducted on 221 pregnant or postpartum CVST patients treated with LMWH at seven Chinese hospitals between January 2010 and January 2025. Patients were divided into effective (191 cases) and ineffective (30 cases) treatment groups. Logistic regression identified predictors, which were then used to develop a risk prediction model.
resultsUnivariate analysis revealed significant factors associated with treatment ineffectiveness: Coronavirus Disease 2019 (COVID-19), hyperthyroidism, platelet (PLT) count, antithrombin III (AT-III), homocysteine (Hcy), low-density lipoprotein cholesterol (LDL-C), protein C, and protein S (all
conclusionsThe developed predictive model, incorporating COVID-19, protein S, and Hcy, effectively assesses the risk of LMWH ineffectiveness in pregnant women with CVST, supporting clinical decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.